DJIA 17,812.19 19.51 0.11%
NASDAQ 5,102.81 0.33 0.01%
S&P 500 2,089.14 2.55 0.12%
market minute promo

Novartis (NYSE: NVS)

86.40 -0.25 (-0.29%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NVS $86.40 -0.29%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $85.90
Previous Close $86.65
Daily Range $85.83 - $86.76
52-Week Range $85.78 - $106.84
Market Cap $207.0B
P/E Ratio 23.42
Dividend (Yield) $2.67 (2.6%)
Ex-Dividend Date
Dividend Pay Date
Volume 1,626,754
Average Daily Volume 1,708,778
Current FY EPS $5.16




Drug Makers

Novartis (NVS) Description

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products. Website:

News & Commentary Rss Feed

The FDA Approves Exelixis, Inc's New Cancer Drug

The Swiss are on the offensive against cancer.

Health Care Sector Update for 11/24/2015: SYN, NVS, BIIB

Biogen's (BIIB) Biosimilar of Pfizer's Enbrel Gets CHMP Nod

Perrigo Company (PRGO) Ex-Dividend Date Scheduled for November 24, 2015

3 Dividend Stocks You Don't Have to Babysit

Looking for a few dividend-paying stocks that don't require constant attention? You might want to give these three names a hard look.

Pfizer and Allergan combine in biggest drug merger ever

Vanguard FTSE All-World ex-US ETF Experiences Big Inflow

How 1 Specialty-Drug Maker Hopes to Win Back Investor Trust

An increase to its share buyback program and promises to reduce debt could help spark Mallinkcrodt Pharmaceutical's shares.

Controversial CEO takes over cancer drug maker

Novartis: FDA Accepts BLA for Biosimilar Version of Neulasta

See More NVS News...

NVS's Top Competitors

NVS $86.40 (-0.29%)
Current stock: NVS
JNJ $102.04 (-0.71%)
Current stock: JNJ
PFE $31.97 (2.04%)
Current stock: PFE
GSK $40.39 (-0.05%)
Current stock: GSK